Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism
- PMID: 24500811
- DOI: 10.1160/TH13-02-0178
Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism
Abstract
Apart from transporting lipids through the body, the human plasma lipoproteins very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) are also thought to serve as a modality for intra-organismal protein transfer, shipping proteins with important roles in inflammation and thrombosis from the site of synthesis to effector locations. To better understand the role of VLDL and LDL in the transport of proteins, we applied a combination of LTQ ORBITRAP-XL (nLC-MS/MS) with both in-SDS-PAGE gel and in-solution tryptic digestion of pure and defined VLDL and LDL fractions. We identified the presence of 95 VLDL- and 51 LDL-associated proteins including all known apolipoproteins and lipid transport proteins, and intriguingly a set of coagulation proteins, complement system and anti- microbial proteins. Prothrombin, protein S, fibrinogen γ, PLTP, CETP, CD14 and LBP were present on VLDL but not on LDL. Prenylcysteine oxidase 1, dermcidin, cathelicidin antimicrobial peptide, TFPI-1 and fibrinogen α chain were associated with both VLDL and LDL. Apo A-V is only present on VLDL and not on LDL. Collectively, this study provides a wealth of knowledge on the protein constituents of the human plasma lipoprotein system and strongly supports the notion that protein shuttling through this system is involved in the regulation of biological processes. Human diseases related to proteins carried by VLDL and LDL can be divided in three major categories: 1 - dyslipidaemia, 2 - atherosclerosis and vascular disease, and 3 - coagulation disorders.
Keywords: CD14; CETP; LCAT; PLTP; Proteomics; TFPI-1; anti-microbial peptides; apoAV; apolipoproteins; atherothrombosis; cathepcin D; coagulation; dermicidin; lipopolysaccharide binding protein; lysozyme C; nLC-MS/MS; prenylcysteine oxidase; protein S; prothrombin.
Similar articles
-
Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.J Clin Invest. 1999 Mar;103(6):907-14. doi: 10.1172/JCI5578. J Clin Invest. 1999. PMID: 10079112 Free PMC article.
-
Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.Proteomics. 2009 Mar;9(5):1344-52. doi: 10.1002/pmic.200800566. Proteomics. 2009. PMID: 19253276
-
Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein.Endocrinology. 2009 May;150(5):2368-75. doi: 10.1210/en.2008-1540. Epub 2009 Jan 15. Endocrinology. 2009. PMID: 19147676 Clinical Trial.
-
Recent advances in physiological lipoprotein metabolism.Clin Chem Lab Med. 2014 Dec;52(12):1695-727. doi: 10.1515/cclm-2013-0358. Clin Chem Lab Med. 2014. PMID: 23940067 Review.
-
Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review.Cardiovasc Diabetol. 2022 Dec 5;21(1):272. doi: 10.1186/s12933-022-01703-5. Cardiovasc Diabetol. 2022. PMID: 36471375 Free PMC article. Review.
Cited by
-
Integrative Analysis of Transcriptome-Wide Association Study and mRNA Expression Profiles Identified Candidate Genes and Pathways Associated With Acute Myocardial Infarction.Front Genet. 2021 Feb 2;12:616492. doi: 10.3389/fgene.2021.616492. eCollection 2021. Front Genet. 2021. PMID: 33603775 Free PMC article.
-
Chronic kidney disease stage affects small, dense low-density lipoprotein but not glycated low-density lipoprotein in younger chronic kidney disease patients: a cross-sectional study.Clin Kidney J. 2018 Jun;11(3):383-388. doi: 10.1093/ckj/sfx115. Epub 2017 Oct 12. Clin Kidney J. 2018. PMID: 29992019 Free PMC article.
-
Label-Free and Real-Time Detection of Protein Ubiquitination with a Biological Nanopore.ACS Nano. 2017 May 23;11(5):4387-4394. doi: 10.1021/acsnano.6b07760. Epub 2017 Mar 29. ACS Nano. 2017. PMID: 28353339 Free PMC article.
-
Active site competition is the mechanism for the inhibition of lipoprotein-associated phospholipase A2 by detergent micelles or lipoproteins and for the efficacy reduction of darapladib.Sci Rep. 2020 Oct 14;10(1):17232. doi: 10.1038/s41598-020-74236-0. Sci Rep. 2020. PMID: 33057060 Free PMC article.
-
ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid.Biology (Basel). 2019 Jul 12;8(3):53. doi: 10.3390/biology8030053. Biology (Basel). 2019. PMID: 31336888 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous